5Fleisch H. Mechanisms of action of the bisphosphonates[J]. Medicina, 1997,57 Suppl 1:65-75.
6Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new member of the tumor factor receptor and ligand families [ J ]. Endoer Rev, 1999,20 ( 3 ) : 345 -357.
7Theolcyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/ RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling[ J ]. Cytokine Growth Factor Rev,2004,15 (6) :457-475.
8Zou W, Hakim I, Tschoep K,et al. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism[J]. J Cell Biochem,2001,83( 1 ) :70-83.
9Sabokbar A, Kudo O, Athanasou NA, et al. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis[ J ]. J Ortho Res,2003,21 ( 1 ) :73-80.
10Schlesinger PH, Blair HC, Teitelbaum SL, et al. Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption[J]. J Biol Chem,1997,272(6) :18636-18643.
